OCLN and inflammatory bowel disease: TJs such as occludin have shown to be downregulated in human patients with inflammatory bowel diseases (Crohn’s disease), and in chickens under nutritional gut health challenge condition models [69,70], therefore revealing the fundamental role of TJs such as occludin in maintaining intestinal barrier integrity.